Effects of immunomodulatory peptides derived from a soil bacterium on cecal microbiota of broilers challenged with Clostridium perfringens

M Kellis, Guiguan Li, Qianning Peng, Yuli Sun, Yong Li, Haitao Li, Jun RenbioRxiv 2022 · DOI

TL;DR

This study investigates how a novel peptide derived from a soil bacterium (BT peptide) influences the gut microbiome of broiler chickens challenged with Clostridium perfringens, a common cause of necrotic enteritis. The findings reveal that BT peptide modulates the cecal microbiota differently than traditional antibiotics, suggesting its potential as a gut health promoter in poultry.

What Problem Does This Paper Address?

Clostridium perfringens infection is a significant economic concern in the poultry industry, leading to necrotic enteritis and reduced broiler performance. Antibiotics have been used to combat these infections, but concerns about antibiotic resistance and residue accumulation are driving the search for alternatives. Probiotics and other feed additives that can modulate the gut microbiome and enhance the host's immune system are of great interest. This paper addresses the need to understand how a specific immunomodulatory peptide, BT peptide, derived from Brevibacillus texasporus, affects the complex microbial community in the broiler chicken's cecum, particularly under a C. perfringens challenge, and how its effects compare to conventional antibiotic treatments.

Methods

The researchers employed a combination of experimental design and advanced molecular techniques. Broiler chickens were divided into three groups: a control group fed a basal diet, a group fed a mixture of antibiotics (bacitracin zinc and colistin sulfate), and a group fed the BT peptide. All groups were challenged with C. perfringens. Cecal digesta samples were collected at multiple time points throughout the study.

The core of the analysis involved 16S rRNA gene sequencing to characterize the bacterial communities. This standard technique allows for the identification and quantification of different bacterial taxa present in the samples. The sequencing data was then processed using bioinformatics pipelines like QIIME and USEARCH for quality filtering, denoising, and operational taxonomic unit (OTU) clustering. Taxonomic assignment was performed using the RDP Classifier against the Silva database.

To understand the functional implications of the observed microbial shifts, the researchers utilized PICRUSt (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States). This tool predicts the functional potential of a microbial community based on its 16S rRNA gene sequence data, allowing for insights into metabolic pathways and gene functions.

Statistical analyses included Kruskal-Wallis H tests for alpha diversity, ANOSIM and NMDS for beta diversity, and LEfSe (Linear Discriminant Analysis Effect Size) to identify differentially abundant taxa and pathways.

Datasets

The study utilized cecal digesta samples collected from 240 broiler chickens over an 18-day experimental period. Samples were collected at three key time points: at the start of the challenge (T1), 1 day post-challenge (T2), and 7 days post-challenge (T3). A total of 65 cecal samples were analyzed. The raw sequence data is available at the NCBI Sequence Read Archive (SRA) database under accession number SRP144400. No new benchmark datasets were introduced.

Key Insights and Ideas

  • BT peptide offers a distinct microbial modulation strategy: Unlike antibiotics, which might broadly suppress microbial populations, BT peptide appears to selectively influence the gut ecosystem, promoting beneficial bacteria and potentially altering metabolic functions.
  • Gut microbiota is dynamic and responsive to challenge and treatment: The study clearly demonstrates that the cecal microbial community composition changes significantly over time, influenced by both the C. perfringens challenge and the dietary interventions.
  • Early life gut colonization is crucial: The research highlights the importance of the early establishment of gut microbiota for host health and immune development, with implications for how feed additives can be most effective.
  • Functional predictions reveal metabolic shifts: The PICRUSt analysis provides a glimpse into how BT peptide might be influencing nutrient utilization and host metabolism through its impact on specific microbial pathways.

Key Results

  • Microbial community composition differed significantly between the treatment groups and over time.
  • Antibiotic treatment (AB) and BT peptide treatment (BT) both led to increased microbial diversity and higher relative abundances of Alistipes sp. CHKCI003 and Faecalibacterium, while decreasing Escherichia coli abundance compared to the control group (CP).
  • At the end of the trial (T3), the BT peptide-supplemented group's cecal microbiota was dominated by Bacteroidaceae.
  • Predicted functional analysis showed enrichment of genes involved in ion-coupled transporters and sugar and biotin metabolism in the BT peptide treatment group.
  • The C. perfringens challenge successfully induced a subclinical necrotic enteritis model, as evidenced by changes in gut contents and intestinal lesions.

Limitations and Future Work

The authors acknowledge that while PICRUSt provides valuable functional predictions, it is an inference and not a direct measurement of gene expression or metabolic activity. Further studies using metatranscriptomics or metabolomics would be needed to confirm these functional predictions.

The study suggests that BT peptide and antibiotics have different influences on the cecal microbiota. Future research should focus on a more explicit investigation of the host-microbe interaction to fully understand the immunomodulatory activity of BT peptide. This could involve detailed studies on how BT peptide influences immune gene expression in the gut and how this relates to the observed microbial shifts. The potential of BT peptide as a novel antibiotic alternative for livestock species warrants further exploration.

Summary updated

Abstract

Abstract Brevibacillus texasporus peptide (BT peptide) is immunomodulatory in poultry as a feed additive to substitute antibiotics. In the present study we performed 16S rRNA gene sequencing to compare development of the cecal microbial communities in Clostridium perfringens -challenged broilers fed basal diet only or with either BT peptide (48 ppm) or antibiotics mixture (20 ppm bacitracin zinc and 40 ppm colistin sulfate). 240 chicks were randomly assigned into each treatment and a total of 65 cecal samples were collected at the beginning, during seven challenge days and one week post challenge. The composition of microbial communities was clearly distinguishable over time. Treatments with challenge and the antibiotics mixture were associated with increased diversity and with higher relative abundances of Alistipes sp. CHKCI003 and Faecalibacterium and lower abundance of Escherichia coli (all p < 0.05). At the termination of the trial, the cecal microbiota in broilers supplemented with BT peptide was dominated by members of Bacteroidaceae. Predicted function analysis reveals significant enrichment of genes involved in ion-coupled transporters and sugar and biotin metabolism in the BT peptide treatment. Taken together, our results suggest that BT peptide and commonly used antibiotics have different influences on modulating the composition of cecal microbiota in broilers.
BibTeX
@misc{kellis2022effects,
  author = {M Kellis and Guiguan Li and Qianning Peng and Yuli Sun and Yong Li and Haitao Li and Jun Ren},
  title = {{Effects of immunomodulatory peptides derived from a soil bacterium on cecal microbiota of broilers challenged with <i>Clostridium perfringens</i>}},
  year = {2022},
  doi = {10.1101/2022.03.06.480873},
  howpublished = {bioRxiv},
}
Figure